Search by Drug Name or NDC

    NDC 60505-4631-03 CycloSPORINE, Modfied 50 mg/1 Details

    CycloSPORINE, Modfied 50 mg/1

    CycloSPORINE, Modfied is a ORAL CAPSULE, LIQUID FILLED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is CYCLOSPORINE.

    Product Information

    NDC 60505-4631
    Product ID 60505-4631_63e0d9d4-3eb3-2015-35ca-65921091cc49
    Associated GPIs 99402020300130
    GCN Sequence Number 023885
    GCN Sequence Number Description cyclosporine, modified CAPSULE 50 MG ORAL
    HIC3 Z2E
    HIC3 Description IMMUNOSUPPRESSIVES
    GCN 13916
    HICL Sequence Number 010086
    HICL Sequence Number Description CYCLOSPORINE, MODIFIED
    Brand/Generic Generic
    Proprietary Name CycloSPORINE, Modfied
    Proprietary Name Suffix n/a
    Non-Proprietary Name Cyclosporine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, LIQUID FILLED
    Route ORAL
    Active Ingredient Strength 50
    Active Ingredient Units mg/1
    Substance Name CYCLOSPORINE
    Labeler Name Apotex Corp.
    Pharmaceutical Class Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210721
    Listing Certified Through 2024-12-31

    Package

    NDC 60505-4631-03 (60505463103)

    NDC Package Code 60505-4631-3
    Billing NDC 60505463103
    Package 30 BLISTER PACK in 1 CARTON (60505-4631-3) / 5 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
    Marketing Start Date 2019-11-05
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.20979
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description CYCLOSPORINE MODIFIED 50 MG
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis